In the latest installment of our series on the scientific and investment implications of COVID-19, Biotech Analyst Agustin Mohedas discusses how efforts to develop treatments and vaccines have accelerated innovation in health care. He also provides insight on the potential impact of certain states reopening their economies and what the timeline to develop an effective vaccine could look like.

In our latest episode, Michael Futterman, Head of Knowledge Labs® Professional Development, interviews Dr. Heidi Hanna, Chief Energy Officer of Synergy Brain Fitness. Dr. Hanna explains why she views stress not as “good” or “bad,” but rather as a form of stimulus that has the potential to fuel positive change. She also shares ideas on how we can control our stress – and even take advantage of it – during this time of uncertainty.

The search for an effective COVID-19 treatment is gaining momentum, with public and private entities partnering to speed the process. In this fourth installment on the scientific and investment implications of COVID-19, Portfolio Manager and Research Analyst Dan Lyons explains the latest drug developments, as well as whether the U.S. can meet aggressive testing goals to reopen the economy.

In the third installment of our series on the scientific and investment implications of COVID-19, Health Care Analyst Rich Carney discusses how the health care system has responded to the crisis, how federal and private funding has factored into that response, and why certain emerging trends in the sector, such as telemedicine, will likely accelerate post-pandemic.

Visit the 'Episode Website' for the video version of this episode.

In the second installment of our series on the scientific and investment implications of COVID-19, Biotech Analyst Agustin Mohedas provides insights on how biotech and pharmaceutical companies are responding to the crisis, and why continued systematic testing for the virus is crucial to the eventual reopening and recovery of the U.S. economy.

Visit the 'Episode Website' for the video version of this episode.

In the first of a series on the scientific and investment implications of the coronavirus pandemic, Global Life Sciences Portfolio Manager Andy Acker and Biotech Analyst Agustin Mohedas discuss recent developments to curtail the spread of COVID-19 and how they view the timeline for an eventual return to normalcy in the global economy.

Visit the 'Episode Website' for the video version of this episode.

In the latest edition of Plan Talk, Retirement Director Ben Rizzuto covers some key areas of the SECURE Act that could impact the retirement plan landscape, including the Multiple Employer Plan provision and the elimination of the stretch IRA. This deep dive into the new legislation offers ideas plan sponsors can use to help participants better understand the benefits available to them.

John L. Evans, Jr., Head Strategist of Knowledge Labs™, speaks with bestselling author Dr. Joseph Michelli about what advisors can do to engage meaningfully with clients during these difficult times. Anticipating and meeting clients’ unstated needs is key, as is finding creative and sincere ways to show support and solidarity.

In the latest episode of Plan Talk, Retirement Director Ben Rizzuto discusses the implications of two recent fiduciary breach cases. The first case highlights the issue of equity funds being too highly correlated and fixed income options too limited within retirement plans. The second case, filed against the Retail Employee’s Superannuation Trust in Australia, questions whether plan sponsors have a fiduciary responsibility to consider how ESG factors such as climate change may impact participant assets.

John Evans, Ed.D., Head Strategist of Knowledge Labs™ at Janus Henderson, interviews Dr. Joseph Michelli, speaker, organizational consultant and New York Times bestselling author. His most recent book, “The Airbnb Way: 5 Leadership Lessons for Igniting Growth through Loyalty, Community and Belonging,” outlines strategies for creating tremendous client experiences and improving team culture.